Galanin inhibits performance on rodent memory tasks

Michael Mcdonald, Theresa C. Gleason, John K. Robinson, Jacqueline N. Crawley

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Central administration of galanin produces performance deficits on a variety of rodent learning and memory tasks. Galanin impairs acquisition and/or retention of the Morris water task, delayed nonmatching to position, T-maze delayed alternation, starburst radial maze, and passive avoidance in normal rats. A primary site of action is the ventral hippocampus, with an additional modulatory site in the medial septum-diagonal band. The behavioral actions of galanin at rat septohippocampal sites mediating cognitive processes are consistent with previous reports of inhibitory actions of galanin on acetylcholine release and cholinergically activated transduction at the M1 muscarinic receptor in rat hippocampus. The peptidergic galanin receptor antagonist M40 blocks the inhibitory actions of galanin on memory tasks. Treatment combinations of M40 with an M1 agonist, TZTP, improves performance on delayed nonmatching to position, in rats with 192IgG-saporin-induced cholinergic lesions of basal forebrain neurons. Nonpeptide, bioavailable, subtype-selective galanin receptor antagonists may provide tools to test the hypothesis that antagonism of endogenous galanin, which is overexpressed in the basal forebrain in Alzheimer's patients, can contribute to the alleviation of the cognitive deficits associated with Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)305-322
Number of pages18
JournalAnnals of the New York Academy of Sciences
Volume863
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Galanin
Rodentia
Data storage equipment
Rats
Galanin Receptors
Hippocampus
Muscarinic M1 Receptors
Cholinergic Agents
Acetylcholine
Neurons
Rat
Rodent
Alzheimer Disease
Learning
Water
Maze
Antagonist

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Galanin inhibits performance on rodent memory tasks. / Mcdonald, Michael; Gleason, Theresa C.; Robinson, John K.; Crawley, Jacqueline N.

In: Annals of the New York Academy of Sciences, Vol. 863, 01.01.1998, p. 305-322.

Research output: Contribution to journalArticle

Mcdonald, Michael ; Gleason, Theresa C. ; Robinson, John K. ; Crawley, Jacqueline N. / Galanin inhibits performance on rodent memory tasks. In: Annals of the New York Academy of Sciences. 1998 ; Vol. 863. pp. 305-322.
@article{ee4b90374bc24a93b91704157d3e3356,
title = "Galanin inhibits performance on rodent memory tasks",
abstract = "Central administration of galanin produces performance deficits on a variety of rodent learning and memory tasks. Galanin impairs acquisition and/or retention of the Morris water task, delayed nonmatching to position, T-maze delayed alternation, starburst radial maze, and passive avoidance in normal rats. A primary site of action is the ventral hippocampus, with an additional modulatory site in the medial septum-diagonal band. The behavioral actions of galanin at rat septohippocampal sites mediating cognitive processes are consistent with previous reports of inhibitory actions of galanin on acetylcholine release and cholinergically activated transduction at the M1 muscarinic receptor in rat hippocampus. The peptidergic galanin receptor antagonist M40 blocks the inhibitory actions of galanin on memory tasks. Treatment combinations of M40 with an M1 agonist, TZTP, improves performance on delayed nonmatching to position, in rats with 192IgG-saporin-induced cholinergic lesions of basal forebrain neurons. Nonpeptide, bioavailable, subtype-selective galanin receptor antagonists may provide tools to test the hypothesis that antagonism of endogenous galanin, which is overexpressed in the basal forebrain in Alzheimer's patients, can contribute to the alleviation of the cognitive deficits associated with Alzheimer's disease.",
author = "Michael Mcdonald and Gleason, {Theresa C.} and Robinson, {John K.} and Crawley, {Jacqueline N.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1111/j.1749-6632.1998.tb10704.x",
language = "English (US)",
volume = "863",
pages = "305--322",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Galanin inhibits performance on rodent memory tasks

AU - Mcdonald, Michael

AU - Gleason, Theresa C.

AU - Robinson, John K.

AU - Crawley, Jacqueline N.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Central administration of galanin produces performance deficits on a variety of rodent learning and memory tasks. Galanin impairs acquisition and/or retention of the Morris water task, delayed nonmatching to position, T-maze delayed alternation, starburst radial maze, and passive avoidance in normal rats. A primary site of action is the ventral hippocampus, with an additional modulatory site in the medial septum-diagonal band. The behavioral actions of galanin at rat septohippocampal sites mediating cognitive processes are consistent with previous reports of inhibitory actions of galanin on acetylcholine release and cholinergically activated transduction at the M1 muscarinic receptor in rat hippocampus. The peptidergic galanin receptor antagonist M40 blocks the inhibitory actions of galanin on memory tasks. Treatment combinations of M40 with an M1 agonist, TZTP, improves performance on delayed nonmatching to position, in rats with 192IgG-saporin-induced cholinergic lesions of basal forebrain neurons. Nonpeptide, bioavailable, subtype-selective galanin receptor antagonists may provide tools to test the hypothesis that antagonism of endogenous galanin, which is overexpressed in the basal forebrain in Alzheimer's patients, can contribute to the alleviation of the cognitive deficits associated with Alzheimer's disease.

AB - Central administration of galanin produces performance deficits on a variety of rodent learning and memory tasks. Galanin impairs acquisition and/or retention of the Morris water task, delayed nonmatching to position, T-maze delayed alternation, starburst radial maze, and passive avoidance in normal rats. A primary site of action is the ventral hippocampus, with an additional modulatory site in the medial septum-diagonal band. The behavioral actions of galanin at rat septohippocampal sites mediating cognitive processes are consistent with previous reports of inhibitory actions of galanin on acetylcholine release and cholinergically activated transduction at the M1 muscarinic receptor in rat hippocampus. The peptidergic galanin receptor antagonist M40 blocks the inhibitory actions of galanin on memory tasks. Treatment combinations of M40 with an M1 agonist, TZTP, improves performance on delayed nonmatching to position, in rats with 192IgG-saporin-induced cholinergic lesions of basal forebrain neurons. Nonpeptide, bioavailable, subtype-selective galanin receptor antagonists may provide tools to test the hypothesis that antagonism of endogenous galanin, which is overexpressed in the basal forebrain in Alzheimer's patients, can contribute to the alleviation of the cognitive deficits associated with Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=0032438438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032438438&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1998.tb10704.x

DO - 10.1111/j.1749-6632.1998.tb10704.x

M3 - Article

VL - 863

SP - 305

EP - 322

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -